4//SEC Filing
Call Matthew 4
Accession 0001209191-22-018666
CIK 0001808865other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 7:58 PM ET
Size
9.2 KB
Accession
0001209191-22-018666
Insider Transaction Report
Form 4
Call Matthew
Chief Operating Officer
Transactions
- Award
Option (right to buy)
2022-03-11+85,000→ 85,000 totalExercise: $36.21Exp: 2032-03-11→ Common Stock (85,000 underlying)
Footnotes (1)
- [F1]This stock option shall vest over 4 years, with 25% vesting on March 11, 2023 and thereafter in equal monthly installments over the next 36 months, subject to the Reporting Person's continued service to the Issuer.
Documents
Issuer
iTeos Therapeutics, Inc.
CIK 0001808865
Entity typeother
Related Parties
1- filerCIK 0001816207
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 7:58 PM ET
- Size
- 9.2 KB